Interleukin-1 alpha stimulates osteoclast formation from peripheral blood monocytes and increases osteoclastic activity.
Interleukin-1 (IL-1) is produced by monocytes and marrow stromal cells and can stimulate bone resorption in tissue culture. In addition, IL-1 can induce osteoclast-like cell formation in long-term bone marrow culture. However, whether IL-1 can increase osteoclast formation by stimulating fusion of peripheral blood monocytes is not clear. In addition, the precise effect of IL-1 on osteoclastic activity is still not well known. Using the bioassay of osteoclast formation, osteoclast-free fetal calvariae were harvested from 14-day timed-pregnant Sprague-Dawley rats and cultured in BGJb medium for 10 days. On the 10th day, mononuclear cells were obtained from peripheral blood of 8-week-old female Sprague-Dawley rats through cardiac puncture and Ficoll-Paque density gradient separation method and co-cultured with osteoclast-free developing bone explant. On the same day, various concentrations of IL-1 alpha (1,10 or 100 U/ml) were added daily in the experimental dishes while only BGJb medium was added in the controls. In addition, 45Ca release assay and quantitation of nuclei per osteoclast were performed to evaluate the effect of IL-1 alpha on osteoclastic activity. Ten days after adding monocytes, there were 14.25 osteoclasts in the control, without IL-1 alpha; with 1 U of IL-1 alpha, there were 14.75 osteoclasts; with 10 U of IL-1 alpha, there were 18.00 osteoclasts; with 100 U of IL-1 alpha, there were 20.75 osteoclasts. In addition, IL-1 alpha stimulated the release of 45Ca and increased the number of average nuclei per osteoclast dose-dependently, indicating a significant increase in bone resorption. IL-1 alpha could increase osteoclast formation by stimulating the fusion of peripheral blood monocytes. In addition, IL-1 alpha is a potent stimulator of osteoclastic activity.